This document discusses drug-coated stents for preventing restenosis. It summarizes a study showing that stents coated with the immunosuppressant sirolimus reduced restenosis by 50% by inhibiting cell proliferation. While adding dexamethasone provided no additional benefit. If further trials confirm the results, sirolimus-coated stents may become the standard therapy for coronary revascularization. However, questions remain about whether coating and stenting all vulnerable plaques found is the best long-term treatment approach.